On May 4, 2020 Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, reported dates for new data to be presented in abstract presentations at three upcoming medical meetings, as well as a management presentation at an investor conference in Spring 2020 (Press release, Phio Pharmaceuticals, MAY 4, 2020, View Source [SID1234556950]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
American Society of Gene & Cell Therapy (ASGCT) (Free ASGCT Whitepaper) 2020 Annual Meeting
Title:
Adoptive Cell Therapy don’t over engineer it; Alternatives to gene editing to improve cell-based therapeutics for the treatment of cancer
Date:
Tuesday, May 12, 2020
Presenter:
Dr. Simon P. Fricker
Abstract number:
1179
* This will be a virtual event in 2020 due to the COVID-19 pandemic
ASCO20 Virtual Scientific Program
Title:
Intratumoral use of self-delivering RNAi to reprogram the tumor microenvironment and boost the antitumor response
Date:
Friday, May 29, 2020
Presenter:
Dr. Gerrit Dispersyn
Abstract number:
e15206
* This will be a virtual event in 2020 due to the COVID-19 pandemic
American Association for Cancer Research (AACR) (Free AACR Whitepaper) Virtual Annual Meeting II
Title:
Intratumoral delivery of mPH-804 (TIGIT targeting INTASYL compound) inhibits tumor growth and confers an inflammatory tumor microenvironment
Date:
Monday, June 22, 2020
Session Title:
Immune Checkpoints 2
Presenter:
Dr. Simon P. Fricker
Abstract number:
5745
* This will be the second of two AACR (Free AACR Whitepaper) virtual annual meeting events being held in 2020 due to the COVID-19 pandemic
Sachs Associates 6th Annual Digital Immuno-oncology Innovation Forum
Date:
Wednesday, May 27, 2020
Time:
1:00 p.m. CST
Presenter:
Dr. Gerrit Dispersyn
Location:
* This will be a virtual event in 2020 due to the COVID-19 pandemic
The poster presentations and the corporate presentation will be made available under the "Investors – Events and Presentations" section of the Company’s website approximately one hour after each event.